Israel Englander Abeona Therapeutics Inc. Transaction History
Millennium Management LLC
- $192 Billion
- Q4 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Millennium Management LLC holds 2,117,169 shares of ABEO stock, worth $12.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,117,169
Previous 2,301,628
8.01%
Holding current value
$12.7 Million
Previous $14.5 Million
19.22%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding ABEO
# of Institutions
66Shares Held
28.3MCall Options Held
593KPut Options Held
18K-
Adage Capital Partners Gp, L.L.C. Boston, MA3.9MShares$23.5 Million0.04% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.69MShares$22.2 Million0.85% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.53MShares$21.2 Million0.98% of portfolio
-
Western Standard LLC Los Angeles, CA2.08MShares$12.5 Million7.9% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.97MShares$11.8 Million0.0% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $35.8M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...